Investing.com - Financial Markets Worldwide

BB Biotech shares rise 3% after strong Q3 performance

Published 24/10/2025, 11:18
BB Biotech shares rise 3% after strong Q3 performance
NBI
0.57%
BIONn
4.48%

Investing.com -- BB Biotech shares increased 3% on Friday after the company reported one of its strongest quarters in years. The biotech investment firm saw its Net Asset Value (NAV) jump 24% in Swiss francs during the third quarter of 2025, while its share price climbed 20%.

Both metrics significantly outperformed the Nasdaq Biotech Index, which rose 15.6% during the same period.

The company posted a net profit of CHF 448 million for the quarter, a substantial turnaround from the CHF 157 million loss recorded in the third quarter of 2024.

BB Biotech attributed its strong performance to several factors, including broad clinical and regulatory progress across its investment portfolio. The company also benefited from a more favorable macroeconomic environment following the Federal Reserve’s interest rate cut in September.

The return of strategic merger and acquisition activity in the biotech sector further contributed to the company’s quarterly results.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.